#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Rectal cancer Emphysema Lennox-Gastaut syndrome Pyruvate kinase deficiency anaemia Philadelphia chromosome positive Infantile spasms Vulval cancer Fallopian tube cancer Henoch-Schonlein purpura nephritis Giant cell tumour of tendon sheath Fibrosarcoma metastatic Vascular calcification Bronchiectasis Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome Osteosarcoma – Life with Disease Retinoblastoma Progressive multifocal leukoencephalopathy – Treatment Rett syndrome – Treatment Primary immunodeficiency syndrome – Diagnostics Pemphigus – Basic Information Glomerulonephritis membranoproliferative – Treatment Leiomyosarcoma recurrent – Life with Disease Langerhans’ cell histiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tezepelumab Chlorpromazine Hydrochloride MB-001 Aon-D21 Remimazolam Ribociclib ISPAGHULA HUSK Agrostis Stolonifera Pollen Inclisiran Rosuvastatin Fosamprenavir Calcium L-Lysine Acetate Ganciclovir Sodium Anhydrous Glucose Bp Azithromycin Neob 534 Tisotumab Vedotin Enlicitide Chloride LUNSEKIMIG More therapies…

    Learn about Your Condition

    Deafness neurosensory Hyperlipidaemia Psychotic disorder Primary adrenal insufficiency Insulin resistance Osteoarthritis Essential thrombocythaemia Respiratory distress Testicular germ cell cancer Vertebrobasilar stroke Pyoderma gangrenosum Intellectual disability Short-bowel syndrome Pharyngeal cancer stage II Decreased appetite More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Elacestrant
    • Everolimus
    • Betamethasone Sodium Phosphate
    Austria Czechia France Germany Greece Italy +1

  • Antibiotic Treatment with Clindamycin and Benzylpenicillin to Prevent Group G and C Streptococcal Infections in Pregnant Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Beta haemolytic streptococcal infection
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Clindamycin Phosphate
    Finland

  • Study on Esketamine and Aripiprazole with Antidepressants for Treatment-Resistant Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aripiprazole
    • Esketamine
    Spain

  • Study of daridorexant and buprenorphine combination treatment for patients with opioid use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Buprenorphine
    • Naloxone
    • Daridorexant
    Sweden

  • Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Osimertinib
    France Germany Italy Poland Spain

  • Study on the Effectiveness of Sphenopalatine Block for Headache Relief in Patients with Subarachnoid Hemorrhage Using Lidocaine Hydrochloride

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nefopam Hydrochloride
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    France
Previous Page
1 … 311 312 313 314 315 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!